Low insulin response in AD has been recently linked to d‐Ser metabolism by multi‐omics analysis [117, 118], and d‐Ser may also control systemic glucose metabolism via NMDAR activation by blunting insulin secretion from pancreatic β cells [119]. The gene discussed is INS; the disease is Alzheimer disease.